Causaly growth playbook

Build three landing pages: Clinical development (evidence before protocol lock, safety and biomarker review, NDA and BLA support), Medical affairs (evidence-gap maps, medical evidence priorities) and Contract research (sponsor RFP responses and proposal development). Each page shows the work product from the homepage tab, links the matching Causaly Dissected episode and case study, and has a demo form that routes to the right specialist. Then point the new demand generation campaigns at them.

Buyers outside discovery need to see their own workflow before they book a demo, and the content to prove it already exists. The pages also give the Microsoft use case playbooks a public destination.

[ ] Headline in the function's words (e.g. "Build the evidence case before the trial")
[ ] Three workflows the function runs
[ ] One work product shown (brief, dossier, gap map)
[ ] Matching Causaly Dissected episode embedded
[ ] Case study or quote from the same function
[ ] Demo form with a "function" field routed in HubSpot
[ ] Added to Use cases menu, sitemap and Microsoft playbook

• Pages promise more than the product does today

  Scientists sign off every page.

• Thin pages

  Launch only with a case study and an episode on each.

• Your websiteThe Use cases menu has five pages, all early discovery: Target Identification & Prioritization, Biomarker Discovery, Disease Pathophysiology, Target Disease Association and Indication Expansion; Solutions has two (Target Product Profile, Indication Prioritization). There is no use case or solution page for clinical development, medical affairs, safety or contract research: /use-cases/clinical-development and /use-cases/medical-affairs return 404.Source
• Your websiteEvents and webinars: the 2026 "Causaly Dissected" series covers a CRO sponsor RFP response (September 30, 2026), "Clinical Development - When the Trial is Running" (September 9), "Clinical Development - Building the Case Before the Trial" (August 12), translational medicine (July 8) and medical affairs; a Takeda webinar on July 30. The page's featured row still includes "Causaly Connect Live 2023".Source
• Your websiteCase studies (9): recent ones include "How a Top 10 Pharma Company Transformed Clinical Program Evaluation" (March 2026), "Using Causaly to Accelerate Clinical Evidence Validation for FDA Submissions" (January 2026), Eisai (June 2026), and a proposal for a target cut from "3-4 weeks to 1 week". Most stories name the customer only as "Top 10" or "Top 50 Pharma".Source
• News coverageCausaly and Syneos Health partnership (August 18, 2026): Syneos Health "will roll out the Causaly platform across high-impact scientific functions, including therapeutic area expertise, medical advisory, real-world evidence, patient advocacy, and proposal development"; the release says contract research organizations "need infrastructure that enables their scientific experts to move at the pace of discovery".Source
• HiringManager, Demand Generation (London, posted October 7, 2026): "creating demand and converting into pipeline within our Ideal Customer Profile (best-fit customer profile)" through "paid advertising, events, email marketing, webinars, content acquisition"; manage the demand generation budget "optimizing for sustainable growth and ROI"; "Utilize and optimize Hubspot to accurately report on campaign and channel performance"; "Conduct in-depth market research to identify new opportunities for growth".Source
• HiringPartnerships Development Manager (New York, posted October 7, 2026): "Our partnership with Microsoft is central to how we reach enterprise life sciences customers"; owns enablement so "Microsoft sellers, solution architects, and industry advisors can confidently position, demonstrate, and sell"; builds "use case playbooks across drug discovery, translational research, competitive intelligence, clinical development, safety/regulatory, and medical affairs"; "Azure Marketplace transactability, deal registration, joint account planning"; measured on "Microsoft-influenced pipeline, registered co-sell opportunities, and marketplace-transacted revenue".Source

Unpublish or noindex the three test pages and remove them from the sitemap, set Webflow to exclude drafts by default, and retitle the partner pages ("Causaly Partners: data and technology alliances" and "Causaly and Microsoft Discovery"). Add a monthly sitemap check.

Clean indexes keep search and AI assistants focused on the pages that sell, and the Microsoft page gets a title people actually search for.

• A test page is in use for a live experiment

  Check with the team before unpublishing; noindex instead.

• Your websiteSitemap (168 URLs, checked October 22, 2026): 75 blog posts, 20 news items, 18 events, 9 downloads, 9 case studies; it also lists /home-test-copy, /untitledtest and /testing, live pages titled "Home test Copy", "Untitledtest" and "Testing" with no noindex tag, plus two noindexed homepage drafts. /partner and /partners/microsoft both carry the title "Partners".Source
• News coverageSeptember 17, 2026: Causaly became available inside Microsoft 365 Copilot and Teams, invoked from the agent menu or by @mentioning Causaly, extending the Microsoft Discovery collaboration announced at Microsoft Build 2026 in June. The /partners/microsoft page explains the joint workflow and links a solution brief.Source

Tag registrants by episode in HubSpot, then send a four-email track per function: the work product from the episode, the matching case study, a short "bring your own question" session with a Causaly scientist, then a demo invitation. Pass the episode and function to the seller.

People who watched a workflow are ready for the next step in that workflow, not a generic pitch, and the series becomes measurable pipeline.

• Too many emails to senior scientists

  Cap at four and stop on reply.

• Your websiteEvents and webinars: the 2026 "Causaly Dissected" series covers a CRO sponsor RFP response (September 30, 2026), "Clinical Development - When the Trial is Running" (September 9), "Clinical Development - Building the Case Before the Trial" (August 12), translational medicine (July 8) and medical affairs; a Takeda webinar on July 30. The page's featured row still includes "Causaly Connect Live 2023".Source
• HiringManager, Demand Generation (London, posted October 7, 2026): "creating demand and converting into pipeline within our Ideal Customer Profile (best-fit customer profile)" through "paid advertising, events, email marketing, webinars, content acquisition"; manage the demand generation budget "optimizing for sustainable growth and ROI"; "Utilize and optimize Hubspot to accurately report on campaign and channel performance"; "Conduct in-depth market research to identify new opportunities for growth".Source
• Your websiteCase studies (9): recent ones include "How a Top 10 Pharma Company Transformed Clinical Program Evaluation" (March 2026), "Using Causaly to Accelerate Clinical Evidence Validation for FDA Submissions" (January 2026), Eisai (June 2026), and a proposal for a target cut from "3-4 weeks to 1 week". Most stories name the customer only as "Top 10" or "Top 50 Pharma".Source

Produce two or three complete examples on public topics (a well-studied target, a published indication), with citations, contradictions and open questions intact. Offer them as gated downloads on the function pages and in campaigns, and let sellers send them before the first call.

Scientists judge by the quality of the output. Seeing a full dossier answers "is this rigorous?" faster than any slide, and it filters for serious buyers.

• Competitors study the output

  They can already see the marketing; the quality is the moat.

• Topic seen as endorsement

  Use only public literature and say so on the cover.

• Your websiteHomepage (checked October 22, 2026): title "The Agentic AI Platform For Life Sciences", H1 "Expert scientific work. Delivered with AI."; tabs for target assessment, indication expansion, clinical development, medical affairs and discovery & translational research, each showing a finished work product (a "Target evidence dossier", an "Indication opportunity assessment", a "Clinical evidence brief", "Medical evidence priorities"); "Access scientific capabilities through MCP, A2A and APIs"; Microsoft 365 Copilot listed under "Connect your ecosystem".Source
• Your websiteThe only way in is "Request a demo" (a HubSpot form promising "a tailored demo"); there is no trial, sample output or pricing page. The partners page lists Sage as a data partner and Microsoft as a technology alliance, and its "Become a partner" call to action is a contact form.Source
• Competitor researchRivals' own homepages: BenchSci sells EMET as "the agentic research environment for preclinical R&D" with a "Try EMET" button and a pricing link; Elicit says it is "Trusted by over 7 million researchers and 8 of the top 20 pharmaceutical companies"; Elsevier's Embase is "now with AI search" for "systematic reviews, safety monitoring".See the research Source
• Your website"Benchmarking Agentic AI for Life Sciences" (December 4, 2025) sets out a "5-Dimensional Benchmarking Framework" applied to "Causaly Deep Research alongside two other popular Deep Research LLMs". The Scientific Workflows page cites "40M+ abstracts, 550K+ trials, 1.6M+ patents, and 550M+ biomedical facts".Source

Add one required field (function) and one optional field (therapeutic area). Route top 50 pharma domains to the account's client partner and others by function. Send a confirmation email with the matching work product and episode.

A demo that starts with the visitor's own workflow converts better, and account owners see interest from their accounts the same day.

• Longer form lowers submissions

  Only one new required field.

• Your websiteThe only way in is "Request a demo" (a HubSpot form promising "a tailored demo"); there is no trial, sample output or pricing page. The partners page lists Sage as a data partner and Microsoft as a technology alliance, and its "Become a partner" call to action is a contact form.Source
• HiringStrategic Client Partner, US (New York, posted September 8, 2026): a former life sciences strategy consultant at Engagement Manager level or above with "global ownership of the full lifecycle of a portfolio of top 50 global pharma enterprise customers", selling "into the existing client base and prospective new clients across North America, focused on the Top 30 clients", and asked to "Liaise with Product to refine Product Market Messaging".Source
• HiringManager, Demand Generation (London, posted October 7, 2026): "creating demand and converting into pipeline within our Ideal Customer Profile (best-fit customer profile)" through "paid advertising, events, email marketing, webinars, content acquisition"; manage the demand generation budget "optimizing for sustainable growth and ROI"; "Utilize and optimize Hubspot to accurately report on campaign and channel performance"; "Conduct in-depth market research to identify new opportunities for growth".Source

Replace the 2023 card with the latest three episodes and an "upcoming" slot, add a subscribe option for the series, and date every card. Decide whether to bring the customer conference back.

Fresh, dated events show momentum and give returning visitors a reason to subscribe.

• Fewer views of the 2023 recordings

  Keep them in the archive.

• Your websiteEvents and webinars: the 2026 "Causaly Dissected" series covers a CRO sponsor RFP response (September 30, 2026), "Clinical Development - When the Trial is Running" (September 9), "Clinical Development - Building the Case Before the Trial" (August 12), translational medicine (July 8) and medical affairs; a Takeda webinar on July 30. The page's featured row still includes "Causaly Connect Live 2023".Source
• Your websiteAbout page: founded in 2018 by Yiannis Kiachopoulos and Artur Saudabayev; headquarters in London with offices in New York and Greece; "Growing a company 3x every year is hard."Source

For each of the six use cases, build a one-page brief, a three-minute demo video and a co-branded landing page with a deal registration link. Run a monthly office hour for Microsoft sellers and track which pages they send.

Partner sellers share what is easy to share. Tracked pages show which use cases resonate in the Microsoft field.

• Microsoft branding rules

  Clear co-branding with the alliance team first.

• HiringPartnerships Development Manager (New York, posted October 7, 2026): "Our partnership with Microsoft is central to how we reach enterprise life sciences customers"; owns enablement so "Microsoft sellers, solution architects, and industry advisors can confidently position, demonstrate, and sell"; builds "use case playbooks across drug discovery, translational research, competitive intelligence, clinical development, safety/regulatory, and medical affairs"; "Azure Marketplace transactability, deal registration, joint account planning"; measured on "Microsoft-influenced pipeline, registered co-sell opportunities, and marketplace-transacted revenue".Source
• News coverageSeptember 17, 2026: Causaly became available inside Microsoft 365 Copilot and Teams, invoked from the agent menu or by @mentioning Causaly, extending the Microsoft Discovery collaboration announced at Microsoft Build 2026 in June. The /partners/microsoft page explains the joint workflow and links a solution brief.Source
• Your websiteThe Use cases menu has five pages, all early discovery: Target Identification & Prioritization, Biomarker Discovery, Disease Pathophysiology, Target Disease Association and Indication Expansion; Solutions has two (Target Product Profile, Indication Prioritization). There is no use case or solution page for clinical development, medical affairs, safety or contract research: /use-cases/clinical-development and /use-cases/medical-affairs return 404.Source

Package a fixed 30-day pilot for one team: five named scientists, three agreed questions, a weekly check-in with a Causaly scientist and a closing readout. Offer it through Microsoft account teams and to existing customers' adjacent departments.

Pilots inside a tool people already use lower the barrier to yes and give Microsoft sellers a concrete offer.

• Pilots with no owner

  Require a named sponsor before starting.

• News coverageSeptember 17, 2026: Causaly became available inside Microsoft 365 Copilot and Teams, invoked from the agent menu or by @mentioning Causaly, extending the Microsoft Discovery collaboration announced at Microsoft Build 2026 in June. The /partners/microsoft page explains the joint workflow and links a solution brief.Source
• HiringPartnerships Development Manager (New York, posted October 7, 2026): "Our partnership with Microsoft is central to how we reach enterprise life sciences customers"; owns enablement so "Microsoft sellers, solution architects, and industry advisors can confidently position, demonstrate, and sell"; builds "use case playbooks across drug discovery, translational research, competitive intelligence, clinical development, safety/regulatory, and medical affairs"; "Azure Marketplace transactability, deal registration, joint account planning"; measured on "Microsoft-influenced pipeline, registered co-sell opportunities, and marketplace-transacted revenue".Source
• HiringStrategic Client Partner, US (New York, posted September 8, 2026): a former life sciences strategy consultant at Engagement Manager level or above with "global ownership of the full lifecycle of a portfolio of top 50 global pharma enterprise customers", selling "into the existing client base and prospective new clients across North America, focused on the Top 30 clients", and asked to "Liaise with Product to refine Product Market Messaging".Source

For each target account, prepare a short briefing on a public therapy area where it is active: crowded targets, white space and evidence gaps, built with Causaly and clearly sourced. Use it to request a 30-minute executive discussion, then propose a workflow pilot.

Executives respond to a useful view of their own market, and the briefing shows the product's quality without a demo.

• Seen as presumptuous

  Keep it to public data and invite correction.

• HiringStrategic Client Partner, US (New York, posted September 8, 2026): a former life sciences strategy consultant at Engagement Manager level or above with "global ownership of the full lifecycle of a portfolio of top 50 global pharma enterprise customers", selling "into the existing client base and prospective new clients across North America, focused on the Top 30 clients", and asked to "Liaise with Product to refine Product Market Messaging".Source
• Your websiteHomepage (checked October 22, 2026): title "The Agentic AI Platform For Life Sciences", H1 "Expert scientific work. Delivered with AI."; tabs for target assessment, indication expansion, clinical development, medical affairs and discovery & translational research, each showing a finished work product (a "Target evidence dossier", an "Indication opportunity assessment", a "Clinical evidence brief", "Medical evidence priorities"); "Access scientific capabilities through MCP, A2A and APIs"; Microsoft 365 Copilot listed under "Connect your ecosystem".Source
• Your website"Benchmarking Agentic AI for Life Sciences" (December 4, 2025) sets out a "5-Dimensional Benchmarking Framework" applied to "Causaly Deep Research alongside two other popular Deep Research LLMs". The Scientific Workflows page cites "40M+ abstracts, 550K+ trials, 1.6M+ patents, and 550M+ biomedical facts".Source

Package a CRO offer around proposal development and therapeutic area expertise: a landing page, an ROI sheet based on proposals per year, and a 60-day pilot on live RFPs. Target the CRO and functional service provider segment with account-based campaigns.

One public CRO customer plus a clear speed metric is a strong opening for a new segment.

• Partner sensitivity

  Agree public references with Syneos Health first.

• News coverageCausaly and Syneos Health partnership (August 18, 2026): Syneos Health "will roll out the Causaly platform across high-impact scientific functions, including therapeutic area expertise, medical advisory, real-world evidence, patient advocacy, and proposal development"; the release says contract research organizations "need infrastructure that enables their scientific experts to move at the pace of discovery".Source
• Your websiteEvents and webinars: the 2026 "Causaly Dissected" series covers a CRO sponsor RFP response (September 30, 2026), "Clinical Development - When the Trial is Running" (September 9), "Clinical Development - Building the Case Before the Trial" (August 12), translational medicine (July 8) and medical affairs; a Takeda webinar on July 30. The page's featured row still includes "Causaly Connect Live 2023".Source
• Your websiteCase studies (9): recent ones include "How a Top 10 Pharma Company Transformed Clinical Program Evaluation" (March 2026), "Using Causaly to Accelerate Clinical Evidence Validation for FDA Submissions" (January 2026), Eisai (June 2026), and a proposal for a target cut from "3-4 weeks to 1 week". Most stories name the customer only as "Top 10" or "Top 50 Pharma".Source

Rerun the benchmark quarterly on a fixed, published set of scientific questions, invite other vendors to submit, and publish a simple scorecard with method and raw outputs. Turn each release into a webinar and a sales one-pager.

A recurring, transparent benchmark makes Causaly the reference point for "scientific reliability", and each release is news.

• Seen as self-serving

  Publish method and raw outputs; add an external reviewer.

• Your website"Benchmarking Agentic AI for Life Sciences" (December 4, 2025) sets out a "5-Dimensional Benchmarking Framework" applied to "Causaly Deep Research alongside two other popular Deep Research LLMs". The Scientific Workflows page cites "40M+ abstracts, 550K+ trials, 1.6M+ patents, and 550M+ biomedical facts".Source
• Competitor researchRivals' own homepages: BenchSci sells EMET as "the agentic research environment for preclinical R&D" with a "Try EMET" button and a pricing link; Elicit says it is "Trusted by over 7 million researchers and 8 of the top 20 pharmaceutical companies"; Elsevier's Embase is "now with AI search" for "systematic reviews, safety monitoring".See the research Source
• Your websiteBlog (75 posts) is written for scientists and R&D leaders, for example "Why generic chats fail in science", "Building vs buying agentic AI: what executives need to know" and "A CIO's guide to agent orchestration platforms"; the featured story follows a lab scientist who went from AI skeptic to onboarding skeptical colleagues.Source

Create an evaluation kit: a scoring sheet for scientific AI, security and data residency answers, how private data integration works, a provenance test, and a sample pilot plan. Offer it on the demo page and send it after first meetings.

Champions sell internally; giving them the pack shortens the evaluation and keeps the criteria in Causaly's favour.

• Kit goes stale

  Review every quarter.

• Your websiteBlog (75 posts) is written for scientists and R&D leaders, for example "Why generic chats fail in science", "Building vs buying agentic AI: what executives need to know" and "A CIO's guide to agent orchestration platforms"; the featured story follows a lab scientist who went from AI skeptic to onboarding skeptical colleagues.Source
• Your website"Benchmarking Agentic AI for Life Sciences" (December 4, 2025) sets out a "5-Dimensional Benchmarking Framework" applied to "Causaly Deep Research alongside two other popular Deep Research LLMs". The Scientific Workflows page cites "40M+ abstracts, 550K+ trials, 1.6M+ patents, and 550M+ biomedical facts".Source
• HiringStrategic Client Partner, US (New York, posted September 8, 2026): a former life sciences strategy consultant at Engagement Manager level or above with "global ownership of the full lifecycle of a portfolio of top 50 global pharma enterprise customers", selling "into the existing client base and prospective new clients across North America, focused on the Top 30 clients", and asked to "Liaise with Product to refine Product Market Messaging".Source

Identify one or two champions per account, give them a certification, early access to new workflows, a quarterly champions call and a share of the stage in Causaly Dissected. Track seat growth in their departments.

Peer advocates spread usage faster than vendor training, and certified champions become references.

• Champions leave

  Keep two per account.

• Your websiteBlog (75 posts) is written for scientists and R&D leaders, for example "Why generic chats fail in science", "Building vs buying agentic AI: what executives need to know" and "A CIO's guide to agent orchestration platforms"; the featured story follows a lab scientist who went from AI skeptic to onboarding skeptical colleagues.Source
• Your websiteEvents and webinars: the 2026 "Causaly Dissected" series covers a CRO sponsor RFP response (September 30, 2026), "Clinical Development - When the Trial is Running" (September 9), "Clinical Development - Building the Case Before the Trial" (August 12), translational medicine (July 8) and medical affairs; a Takeda webinar on July 30. The page's featured row still includes "Causaly Connect Live 2023".Source
• HiringStrategic Client Partner, US (New York, posted September 8, 2026): a former life sciences strategy consultant at Engagement Manager level or above with "global ownership of the full lifecycle of a portfolio of top 50 global pharma enterprise customers", selling "into the existing client base and prospective new clients across North America, focused on the Top 30 clients", and asked to "Liaise with Product to refine Product Market Messaging".Source

Publish a developer page with endpoint overviews, MCP and A2A setup, example agent recipes (target lookup, evidence check) and a request form for sandbox keys. Promote it to pharma AI and data platform teams.

Platform teams pick the data and reasoning services their agents call. Being easy to call turns Causaly into infrastructure inside the account.

• Support load

  Limit sandbox to qualified accounts.

• Your websiteHomepage (checked October 22, 2026): title "The Agentic AI Platform For Life Sciences", H1 "Expert scientific work. Delivered with AI."; tabs for target assessment, indication expansion, clinical development, medical affairs and discovery & translational research, each showing a finished work product (a "Target evidence dossier", an "Indication opportunity assessment", a "Clinical evidence brief", "Medical evidence priorities"); "Access scientific capabilities through MCP, A2A and APIs"; Microsoft 365 Copilot listed under "Connect your ecosystem".Source
• HiringEvery post describes Causaly as "the world's most advanced biomedical knowledge platform, powered by a high-precision Knowledge Graph and GenAI capabilities", "already used by leading biopharmaceutical organizations", backed by "ICONIQ, Index Ventures, Pentech, and Marathon". Engineering is hiring Senior and Staff Software Engineers for Agentic Workflows in London.Source
• News coverageSeptember 17, 2026: Causaly became available inside Microsoft 365 Copilot and Teams, invoked from the agent menu or by @mentioning Causaly, extending the Microsoft Discovery collaboration announced at Microsoft Build 2026 in June. The /partners/microsoft page explains the joint workflow and links a solution brief.Source

Choose two events for medical affairs and clinical development professionals, run a scientist-led session or workshop on evidence planning, and invite attendees to a Causaly Dissected episode. Use the new function pages as the follow-up destination.

Function-specific events reach the new buyers in a buying frame of mind, and the workshops double as content.

• Low return from booths

  Prefer speaking slots and workshops.

• #1 Give clinical development, medical affairs and CRO teams their own pages, where the newest proof already points

• Your websiteEvents and webinars: the 2026 "Causaly Dissected" series covers a CRO sponsor RFP response (September 30, 2026), "Clinical Development - When the Trial is Running" (September 9), "Clinical Development - Building the Case Before the Trial" (August 12), translational medicine (July 8) and medical affairs; a Takeda webinar on July 30. The page's featured row still includes "Causaly Connect Live 2023".Source
• Your websiteThe Use cases menu has five pages, all early discovery: Target Identification & Prioritization, Biomarker Discovery, Disease Pathophysiology, Target Disease Association and Indication Expansion; Solutions has two (Target Product Profile, Indication Prioritization). There is no use case or solution page for clinical development, medical affairs, safety or contract research: /use-cases/clinical-development and /use-cases/medical-affairs return 404.Source
• HiringManager, Demand Generation (London, posted October 7, 2026): "creating demand and converting into pipeline within our Ideal Customer Profile (best-fit customer profile)" through "paid advertising, events, email marketing, webinars, content acquisition"; manage the demand generation budget "optimizing for sustainable growth and ROI"; "Utilize and optimize Hubspot to accurately report on campaign and channel performance"; "Conduct in-depth market research to identify new opportunities for growth".Source

Publish a library page for every workflow: the scientific question, the method and evidence hierarchy, the inputs, a sample output and who uses it. Link each to a demo of that workflow and add new ones as they ship.

Method pages rank for the questions scientists ask, show depth no rival can fake, and give sellers and Microsoft partners one link per need.

• Giving away the method

  The value is execution at scale, not the outline.

• Your websiteHomepage (checked October 22, 2026): title "The Agentic AI Platform For Life Sciences", H1 "Expert scientific work. Delivered with AI."; tabs for target assessment, indication expansion, clinical development, medical affairs and discovery & translational research, each showing a finished work product (a "Target evidence dossier", an "Indication opportunity assessment", a "Clinical evidence brief", "Medical evidence priorities"); "Access scientific capabilities through MCP, A2A and APIs"; Microsoft 365 Copilot listed under "Connect your ecosystem".Source
• Your website"Benchmarking Agentic AI for Life Sciences" (December 4, 2025) sets out a "5-Dimensional Benchmarking Framework" applied to "Causaly Deep Research alongside two other popular Deep Research LLMs". The Scientific Workflows page cites "40M+ abstracts, 550K+ trials, 1.6M+ patents, and 550M+ biomedical facts".Source
• HiringPartnerships Development Manager (New York, posted October 7, 2026): "Our partnership with Microsoft is central to how we reach enterprise life sciences customers"; owns enablement so "Microsoft sellers, solution architects, and industry advisors can confidently position, demonstrate, and sell"; builds "use case playbooks across drug discovery, translational research, competitive intelligence, clinical development, safety/regulatory, and medical affairs"; "Azure Marketplace transactability, deal registration, joint account planning"; measured on "Microsoft-influenced pipeline, registered co-sell opportunities, and marketplace-transacted revenue".Source
• Your websiteThe Use cases menu has five pages, all early discovery: Target Identification & Prioritization, Biomarker Discovery, Disease Pathophysiology, Target Disease Association and Indication Expansion; Solutions has two (Target Product Profile, Indication Prioritization). There is no use case or solution page for clinical development, medical affairs, safety or contract research: /use-cases/clinical-development and /use-cases/medical-affairs return 404.Source

For each top account, map departments using Causaly and those that could, pick the next department, and run a proof session with that team using its own question. Track expansion revenue per account.

Expansion within approved accounts is faster and cheaper than new logos, and the new workflows make the case.

• Budget sits elsewhere

  Involve the new department's leader early.

• #1 Give clinical development, medical affairs and CRO teams their own pages, where the newest proof already points

• HiringStrategic Client Partner, US (New York, posted September 8, 2026): a former life sciences strategy consultant at Engagement Manager level or above with "global ownership of the full lifecycle of a portfolio of top 50 global pharma enterprise customers", selling "into the existing client base and prospective new clients across North America, focused on the Top 30 clients", and asked to "Liaise with Product to refine Product Market Messaging".Source
• Your websiteCase studies (9): recent ones include "How a Top 10 Pharma Company Transformed Clinical Program Evaluation" (March 2026), "Using Causaly to Accelerate Clinical Evidence Validation for FDA Submissions" (January 2026), Eisai (June 2026), and a proposal for a target cut from "3-4 weeks to 1 week". Most stories name the customer only as "Top 10" or "Top 50 Pharma".Source
• Your websiteHomepage (checked October 22, 2026): title "The Agentic AI Platform For Life Sciences", H1 "Expert scientific work. Delivered with AI."; tabs for target assessment, indication expansion, clinical development, medical affairs and discovery & translational research, each showing a finished work product (a "Target evidence dossier", an "Indication opportunity assessment", a "Clinical evidence brief", "Medical evidence priorities"); "Access scientific capabilities through MCP, A2A and APIs"; Microsoft 365 Copilot listed under "Connect your ecosystem".Source
• News coverageCausaly and Syneos Health partnership (August 18, 2026): Syneos Health "will roll out the Causaly platform across high-impact scientific functions, including therapeutic area expertise, medical advisory, real-world evidence, patient advocacy, and proposal development"; the release says contract research organizations "need infrastructure that enables their scientific experts to move at the pace of discovery".Source

Publish one therapy area report per quarter from public data, with a short free summary and a full gated version. Launch each with an episode and use the findings in outreach to teams active in that area.

Original, recurring data earns press, links and AI citations, and puts Causaly in front of portfolio decision-makers.

• Findings challenged

  Publish method and sources.

• Your website"Benchmarking Agentic AI for Life Sciences" (December 4, 2025) sets out a "5-Dimensional Benchmarking Framework" applied to "Causaly Deep Research alongside two other popular Deep Research LLMs". The Scientific Workflows page cites "40M+ abstracts, 550K+ trials, 1.6M+ patents, and 550M+ biomedical facts".Source
• Competitor researchRivals' own homepages: BenchSci sells EMET as "the agentic research environment for preclinical R&D" with a "Try EMET" button and a pricing link; Elicit says it is "Trusted by over 7 million researchers and 8 of the top 20 pharmaceutical companies"; Elsevier's Embase is "now with AI search" for "systematic reviews, safety monitoring".See the research Source
• HiringStrategic Client Partner, US (New York, posted September 8, 2026): a former life sciences strategy consultant at Engagement Manager level or above with "global ownership of the full lifecycle of a portfolio of top 50 global pharma enterprise customers", selling "into the existing client base and prospective new clients across North America, focused on the Top 30 clients", and asked to "Liaise with Product to refine Product Market Messaging".Source

Build a lookup page on the Bio Graph: enter a target and a disease, see the strongest cited relationships and a link to the full workflow. Limit results, require a work email for more, and route enterprise domains to account owners.

A useful free tool spreads through labs, and enterprise domain sign-ups are warm leads for sellers.

• Cannibalises paid use

  Keep it to one pair and top results.

• Competitor researchRivals' own homepages: BenchSci sells EMET as "the agentic research environment for preclinical R&D" with a "Try EMET" button and a pricing link; Elicit says it is "Trusted by over 7 million researchers and 8 of the top 20 pharmaceutical companies"; Elsevier's Embase is "now with AI search" for "systematic reviews, safety monitoring".See the research Source
• Your websiteHomepage (checked October 22, 2026): title "The Agentic AI Platform For Life Sciences", H1 "Expert scientific work. Delivered with AI."; tabs for target assessment, indication expansion, clinical development, medical affairs and discovery & translational research, each showing a finished work product (a "Target evidence dossier", an "Indication opportunity assessment", a "Clinical evidence brief", "Medical evidence priorities"); "Access scientific capabilities through MCP, A2A and APIs"; Microsoft 365 Copilot listed under "Connect your ecosystem".Source
• Your websiteThe only way in is "Request a demo" (a HubSpot form promising "a tailored demo"); there is no trial, sample output or pricing page. The partners page lists Sage as a data partner and Microsoft as a technology alliance, and its "Become a partner" call to action is a contact form.Source

Offer a fixed-price starter package for venture-backed biotechs, distributed through life science investors and incubators, with a shared onboarding session. Track conversion to full contracts as companies grow.

Biotechs grow into larger customers, and one investor relationship reaches dozens of companies.

• Low revenue per account

  Cap seats and set an upgrade path.

• Your websiteCase studies (9): recent ones include "How a Top 10 Pharma Company Transformed Clinical Program Evaluation" (March 2026), "Using Causaly to Accelerate Clinical Evidence Validation for FDA Submissions" (January 2026), Eisai (June 2026), and a proposal for a target cut from "3-4 weeks to 1 week". Most stories name the customer only as "Top 10" or "Top 50 Pharma".Source
• HiringEvery post describes Causaly as "the world's most advanced biomedical knowledge platform, powered by a high-precision Knowledge Graph and GenAI capabilities", "already used by leading biopharmaceutical organizations", backed by "ICONIQ, Index Ventures, Pentech, and Marathon". Engineering is hiring Senior and Staff Software Engineers for Agentic Workflows in London.Source
• Your websiteAbout page: founded in 2018 by Yiannis Kiachopoulos and Artur Saudabayev; headquarters in London with offices in New York and Greece; "Growing a company 3x every year is hard."Source

Defer non-essential scripts, trim unused CSS and JavaScript from the Webflow build, and check the new landing pages before each campaign launch. Watch the field data monthly.

Cheap insurance: new campaign pages stay as fast as the homepage already is for real visitors.

• Breaking tracking

  Test HubSpot forms after changes.

• Google PageSpeedMobile homepage: lab score 59 and lab LCP 9.8 s, with render-blocking requests (about 2.1 s) and unused JavaScript as the top savings; but real Chrome visitors pass Core Web Vitals (LCP p75 1.1 s, INP 68 ms, CLS 0.01) and LCP improved 32%.Source
• HiringManager, Demand Generation (London, posted October 7, 2026): "creating demand and converting into pipeline within our Ideal Customer Profile (best-fit customer profile)" through "paid advertising, events, email marketing, webinars, content acquisition"; manage the demand generation budget "optimizing for sustainable growth and ROI"; "Utilize and optimize Hubspot to accurately report on campaign and channel performance"; "Conduct in-depth market research to identify new opportunities for growth".Source